Novogen Limited (NASDAQ: NVGN), an Australian/US biotechnology company, advises that it has entered into definitive agreements today to issue approximately ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE